Premium
Risperidone treatment for irritability in ASD produces good outcomes, balancing weight gain
Publication year - 2015
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30071
Subject(s) - irritability , risperidone , tolerability , weight gain , aggression , enuresis , autism , appetite , psychology , medicine , psychiatry , body weight , adverse effect , schizophrenia (object oriented programming) , anxiety
While risperidone has been shown to be effective for short‐term (8‐week and 6‐month) management of severe irritability and aggression in children and adolescents with autism, less is known about long‐term effects. Researchers looked at tolerability, safety, and therapeutic benefits of long‐term use of the medication and found that the risks — weight gain, enuresis, and increased appetite — were balanced by the benefits.